Explore

Companies
Investors
Funds
Markets
Compare

Capbase

About
FAQ
Data & sources
Contribute
API

Compare

Crunchbase alternative
PitchBook alternative

Legal

Terms of Service
Privacy Policy
Takedown policy

REVERAGEN BIOPHARMA, INC. — Funding, Investors & Profile — Capbase

← All companies

Compare History

REVERAGEN BIOPHARMA, INC.

Private

Won 11 federal SBIR/STTR research awards from HHS and other federal agencies.

Department of Health and Human ServicesNational Institutes of Health

SAM UEI: NQA4J3L3E1Z4

Founded: —Source: [GOV]
Headquarters: Vienna, VirginiaSource: [GOV]
Country: United StatesSource: [GOV]
Headcount: 7Source: [GOV]

$0Source: [GOV]Total raised

UndisclosedSource: [GOV]Last valuation

Overview

REVERAGEN BIOPHARMA, INC. has been awarded 11 US Small Business Innovation Research (SBIR/STTR) contracts totalling $11,189,078 between 2010 and 2020. These are non-dilutive federal research grants, not equity financing. The company is based in Vienna, Virginia.

Funding rounds

11 rounds

11 rounds · latest SBIR Phase II award (HHS), Sep 2020

Investors

No investors recorded yet for REVERAGEN BIOPHARMA, INC..

Add an investor

People

Leadership

ERIC P HOFFMANPrincipal investigatorSince 2020Source: [GOV]

JESSE DAMSKERPrincipal investigatorSince 2018Source: [GOV]

Acquisitions

REVERAGEN BIOPHARMA, INC. has no recorded acquisitions.

Add an acquisition

Exits

Still private — no exit on record.

Record an exit

Diversity investments

No diversity signals recorded yet for REVERAGEN BIOPHARMA, INC..

Add diversity data

Data aggregated from SEC EDGAR, Wikidata, and community contributions. Spotted an error? Propose a change or report an issue.

Stage

Seed

Sector

Healthcare